- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06710054
Recording Cyclist Crashes and Long-term Injury Consequences by New Smart Tools
Study Overview
Status
Detailed Description
The ReCyCLIST project is a collaboration between research institutes from the health and transport sciences, public authorities, medical expertise and web-tool developers, and end-user organisations, and as such an excellent example of a project that promotes and supports cooperation between research groups and users of the research.
Three major research questions are addressed in the ReCyCLIST project:
- What are the numbers, characteristics and locations of accidents and injuries among cyclists and e-scooter/micro mobility device users in a representative county (Agder) in Norway?
- What are the consequences of injuries in terms of social and individual costs including long-term consequences with respect to recovery, disability rates etc.?
- What are the overall health impacts of cycling, when including the more comprehensive set of positive and negative effects; and what are the economic impacts from increased cycling (in terms of cost-benefit ratios)? To answer these research questions, the investigators will develop a new digital registration tool to record accidents and injuries among cyclists and users of micro mobility devices in Agder county in Norway. Patients will be followed up and data on medical rehabilitation, recovery and general conditions will be collected by use of questionnaires after three and twelve months. To map long-term consequences of injuries (> 1 year), a retrospective study will be applied based on linking data from different registers containing information about health, welfare benefits and injuries.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Kristiansand, Norway, 4604
- Sorlandet hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All cyclist (including micromobility devices), with recent accidents submitted to out- and in patient clinics in a well defined region of 310 000 inhabitants
Exclusion Criteria:
- No informed consent
- "Patients" not eligible for follow up within our region
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to recover
Time Frame: From the inclusion of bicycle accidents to 12 months after the inclusion
|
Time to recover
|
From the inclusion of bicycle accidents to 12 months after the inclusion
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReCyclist
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.